ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
Dow Jones
39.150,33
0,04%
Euro vs US Dollar
1,06925
-0,09%
Bitcoin
64.267,97
0,28%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ)

  7. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ) News

LGNZZ

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:LGNZZ
DatumZeitQuelleÜberschriftSymbolFirma
19/06/202403h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202403h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202403h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202403h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202403h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/06/202403h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
18/06/202423h14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
17/06/202422h02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
14/05/202400h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
13/05/202423h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
10/05/202400h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
10/05/202400h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
08/05/202422h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/05/202422h03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/05/202413h36Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
05/06/202022h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
08/05/202022h29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
06/05/202022h03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202001h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202001h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202001h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
24/04/202022h10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
24/04/202022h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/04/202022h41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
06/04/202023h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
02/04/202022h19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
13/03/202023h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
27/02/202023h38Edgar (US Regulatory)Annual Report (10-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
18/02/202023h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
18/02/202023h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
 Showing the most relevant articles for your search:USOTC:LGNZZ

Kürzlich von Ihnen besucht

BIT
P1W3T9
NLBNPIT1W3T9 20991231 57...
DGFX
ZLWUSDT
ZELWIN
BOV
CURY3R
Cury Construtora E Incor... ON
LSE
AW47
Bank Mont.34
NASDAQ
NATIV
National Instruments
BITMOT
2673765
Gs Group Mc Oct33 Eur
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten